Daiichi Sankyo
Japan · Pharma & Healthcare
LeaveRussia detail: Scaling Back
Decision trail
Stopped supplying some of their drugs, there are substitutes
Local stats (LeaveRussia)
Glob.Revenue, mln.USD
7711
Status history since 2022
- 03/08/2026 — scaling back · Imported from KSE LeaveRussia
Exposure profile
Full exposure profile is a Professional feature
Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.
Upgrade to Professional